A nomogram with coagulation markers for prostate cancer prediction in patients with PSA levels of 4–20 ng/mL

Background The global incidence of prostate cancer (PCa) is rising, necessitating improved diagnostic strategies. This study explores coagulation parameters' predictive value for clinically significant PCa (csPCa) and develops a nomogram.